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We have cloned a novel human protein tyrosme kinase gene specific to T cells by the polymerase chain reaction method. This gene encodes a 620 
amino-acid polypeptide includmg a catalytic domain for tyrosine kmase, an SH2 domain and an SH3 domain, seemingly belongmg to the SW family. 
However, characteristics of a long unique N-terminal stretch and lack of a myristylation site at the N-terminus and of a kinase regulatory tyrosme 
residue in the C-terminus classify this molecule into a new subfamily comprismg recently cloned mouse tee. itkltsk and human atklbpk genes. This 
gene was transcriptionally induced in normal T cells by interleukin 2 stimulation. These results suggest the crucial roles of this gene in T cell 
proliferation and differentiation. 
Protein tyrosine kinase; Molecular clonmg; Interleukm 2: T cell 
1. INTRODUCTION 
Extracellular stimuli responsible for cell activation 
and proliferation exert their function through interac- 
tion with cell surface receptors which generate intracel- 
lular signaling pathways. One group of receptors is 
characterized by protein tyrosine kinase domains in the 
cytoplasmic regions of receptor molecules. This group 
includes receptors for growth factors such as platelet- 
derived growth factor (PDGF), epidermal growth fac- 
tor (EGF) and colony-stimulating factor-l (CSF-1) (re- 
viewed in [l]). The second group is a cytokine receptor 
family in which association of receptor subunits yields 
functional receptors. No enzymatic activity has been 
reported in these subunits, but tyrosine kinase mole- 
cules are suggested to be associated with the intracyto- 
plasmic regions of the receptor subunits. Receptors for 
cytokines such as interleukin 2 (IL-2), IL-3, IL-5, IL-6 
and granulocyte-macrophage colony-stimulating factor 
(GM-CSF) belong to the second group family (reviewed 
in [2]). 
In both receptor groups, signal pathways induced by 
extracellular interaction between ligands and receptors 
include protein phosphorylation that is detected as one 
of the earliest biochemical reactions; in particular, im- 
mediate tyrosine phosphorylation following the ex- 
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tracellular interaction, highlights the significance of ac- 
tivation of tyrosine kinases associated with receptors in 
signal pathways. 
In the course of our studies of tyrosine phosphoryla- 
tion induced by IL-2, we observed that IL-2-dependent 
tyrosine phosphorylation was induced even in cells lack- 
ing a cytoplasmic tyrosine kinase, ~56’~~ [3-51, that had 
been reported to be directly associated with the IL-2- 
receptor B subunit [6]. We thereby wished to explore a 
tyrosine kinase molecule involved in the IL-Zinduced 
signaling pathway. The polymerase chain reaction 
(PCR) with primers encoding peptides common to pro- 
tein kinases was utilized for cloning tyrosine kinase 
genes expressed specifically in T cells. We found a novel 
tyrosine kinase, related to but distinct from the previ- 
ously identified src family, expression of which is re- 
stricted to T cell and natural killer cell lineages. During 
analysis of this gene, we learned that mouse and human 
tyrosine kinase genes highly homologous to our clone 
have been cloned from T cells and B cells, respectively, 
indicating the establishment of a novel tyrosine kinase 
family. 
We report here properties of a cloned novel tyrosine 
kinase gene. 
2. MATERIAL AND METHODS 
2.1. Cells 
MT-l, MT-2, HUT 102. TL-Mor, ILT-Mat, TL-Su and TCL-Kan 
are human T cell lines carrying human T-cell leukemia virus type-1 
(HTLV-I). MTB-1 is a stable transformant of MT-l with the IL-2 
receptor /I chain gene, resulting in the generation of the functional 
high-affinity IL-2 receptor with the endogenous IL-2 receptor a and 
y chains [3]. Jurkat and MOLT-4 are human acute lymphocyttc leuke- 
mia T cell lines. YTC3 is a natural killer cell line. Ran, LCL-Kan and 
LCL-Ter28 are Epstein-Barr virus transformed B cell lines. BALL-l. 
Publrshed by Elsevier Science Publishers B. V. 
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Daudi and Ramos are B-cell lymphoma cell lines These cells were 
maintained m RPM1 1640 medium supplemented with 10% fetal calf 
serum, 2 mM L-glutamine and antibiotics at 37°C under 7% CO, m 
air. For the IL-2-dependent cell Ime. ILT-Mat, IL-2 was added up to 
500 pM. Human peripheral blood lymphocytes (PBL) were prepared 
by standard procedures of Ftcoll-Conray gradient centrifugation and 
cultured with phytohemagglutmin (PHA) (I mg/ml of medium: Dtfco) 
with recombinant IL-2 (1 nM; AJmomoto) in RPM1 1640 with 10% 
fetal calf serum. 
2.2. RNA prepmatron 
Total cellular RNA was isolated from each cell line by extraction 
with guanidinmm thiocyanate and centrifugation through a 5.7 M 
CsCl cushion [7]. Poly(A)‘RNA of PHA-PBL was enriched from total 
RNA with an oligo-(dT) column. 
2.3. cDNA clonmg 
First cDNA strand was generated from PHA-PBL mRNA by the 
standard method The first strand was subjected to PCR amphfication 
of 25 serial cycles of I mm at 94°C. 2 mm at 50°C and 3 mm at 72°C 
with a pair of the degenerate primers for regions common to protein 
tyrosme kmases. After size fractionation, the PCR products were 
subcloned into pUCl9 and sequenced by the dideoxynucleotide chain 
termination method with Sequenase ver.2.0 (LJSB). 
An as yet uncharacterized tyrosine kinase related fragment, clone 
pTK-I I, was used as a probe to obtain a full-length cDNA clone from 
a PHA-PBL cDNA library m AZAP II (Stratagene) under high-strm- 
gent conditions. A clone carrying the longest insert (4.4 kbp). named 
pN2 was fully sequenced on both strands. 
2.4. RNA blot urzal~.~~~ 
Total RNA was size-fractionated by electrophoresis on a formalde- 
hydeeagarose gel and blotted to Hybond-N membranes (Amersham). 
Membranes were UV cross-linked and subJected to hybridization. A 
4.4-kbp fragment specific for the cloned protein kinase gene and a 
I.?-kbp PstI fragment from pGAD-28 for the glyceraldehyde-3-phos- 
phate dehydrogenase (GAPDH) gene were used as probes [7]. Probes 
were labeled with random primers. [a-“‘P]dCTP (Amersham) and T7 
polymerase (Pharmacia). Hybridization was performed for 20 h at 
42°C in 50% formamide. 5 x Denhardt’s solution. 5 x SSC, 0 I% SDS. 
10% dextran sulfate. 20 mM Tris-HCI (pH 7.5) and 200 fig/ml soni- 
cated and denatured salmon sperm DNA. Membranes were washed 
in 2 x SSC and 0.1% SDS three times at room temperature and at 
65°C with the same solution Radioactivity was analyzed with a bio- 
image analyzer BAS 2000 (Fuji Film). 
3. RESULTS AND DISCUSSION 
Isolation of novel tyrosine kinase genes in T cells was 
carried out by PCR with primers of degenerate oligonu- 
cleotides corresponding to two regions of the catalytic 
domain conserved in protein kinases. The degenerate 
primers are 17-mer sense and antisense oligonucleotide 
primers derived from K(I/V)(A/G)DFG in the VII and 
DVWS(FN)G in the IX, respectively. among the 11 
highly homologous regions (I-XI) of the conserved cat- 
alytic domain of protein kinases ranging over about 250 
amino acids [8]. The first cDNA strand reverse-tran- 
scribed from PHA-stimulated PBL mRNA was used in 
PCR amplification. PCR products were digested with 
&$I and Hue11 to eliminate the fragment from theJ~~~z 
and Iek genes dominantly expressed in T cells [9911], 
separated on an acrylamide gel and then 140-l 60 base 
pairs (bp) fragments were recovered, which correspond 
with the expected length. The fragments were cloned 
2 
and sequenced. Among 24 clones, a half had nucleotide 
sequences identical to previously identified genes such 
as protein kinaseC-@ (PKCP) [ 121, basic-fibroblast 
growth factor(bFGF)-receptor [ 131. PDGF-receptor /I 
[14], and another half encoded polypeptides related to 
protein kinases but distinct from published sequences. 
Ten out of the 12 unidentified clones were the same, 
having homology to yeast polymyxin B resistance gene 
[ 151. One of the remaining two resembled serineithreon- 
ine kinases and the other seemed to stem from an uni- 
dentified tyrosine kinase. Thus we focused our attention 
on the unidentified putative tyrosine kinase clone. Its 
whole cDNA was isolated from a human PHA-PBL 
cDNA library using the cloned fragment as a probe. 
Out of fifteen clones containing identical sequences, the 
longest clone. pN2, was further analyzed. The pN2 
clone carried a 4,384-bp insert, which contained an 
open reading frame encoding 620 amino-acid polypep- 
tide with a calculated molecular weight of 71,827 (Fig. 
1A). 
The deduced amino acid sequence predicted a possi- 
ble catalytic domain for protein kinase with a stretch of 
250 amino acids at residues 363-612. This included sev- 
eral characteristics to protein kinases like an ATP-bind- 
ing site, GSGQFG at positions 370-375, with a K resi- 
due at position 391, the highly conserved DFG motif, 
at positions 500&502, involved in ATP binding, and the 
SPE/APE motif, at positions 526-528. representing the 
most typical sequence of protein kinases. In addition to 
these sequences common to protein kinases, several 
other motifs specific for tyrosine kinases were included; 
DLAARN in subdomain VI and PVKWASPE in sub- 
domain VIII. Moreover. a putative autophosphoryla- 
tion site corresponding to the tyrosine residue at posi- 
tion 416 in c-src was present at position 512 in this 
molecule [8]. These characters presumably indicated 
that the clone encodes a novel tyrosine kinase. 
The putative tyrosine kinase also showed homology 
to Src homology 2 (SH2) and Src homology 3 (SH3) 
domains (reviewed in [16]), which are seen in tyrosine 
kinases and other members of cytoplasmic signal 
transducing molecules. The SH2 and SH3 domains in 
Fig. I. (A) Deduced amino acid sequence of human itkltsk (h-Itk) in 
comparison with mouse rrk (m-Itk). human utk (h-Atk) and mouse tee 
type 1 (m-Tecl). Mouse tsk (not shown) has 6 ammo-acid deletion 
(TLVYLQ at position 82.-87 of mouse Irk) and 1 ammo-acid replace- 
ment (A to R at position I58 of mouse irk) compared with mouse Irk. 
Residues found in human ifkltsk that are identical to others are 
shaded. Gaps (indicated by dashes) are introduced to optimize the 
alignment. The SH2. SH3 and kmase catalytic domains described m 
the text are indicated by dashed underlines. PCR primers used for 
clonmg are indicated by arrows. The tyrosine residue corresponding 
to the putative autophosphorylation site 1s mdicated by an asterisk. 
The nucleotide sequence data of the gene will appear in the DDBJ, 
EMBL and GenBank Nucleottde Sequence Databases with the acces- 
sion number D13720 
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h-Itk MNNFILLEEQ-LIKKSQQKRRTSPSWFKVRPP~T--KASLA-Y-FEDRRG~KRTLK-GSI--ELSRI 60 
m-Itk ~JFIUEEa-LIKKSQQKRRTSPSM'KVFBVLT--KASLA-Y-FEDRLIGKKRTLR-GSI--ELSR~ 60 
h-Atk IUIAAVTL-ESIFL-KRSaQKKKTSPLNFKKRLPLL~J~LSYYEYDFE-R-GR-RGSKKGS~D~~K--~ 61 
m-Tecl M~-----_------sF_-----P-_____V-____--_~~N-----~---H_-----___~---__~-- 14 
h-Itk KCVEIV---K--------------sa----ISr----pCBYMPFQ--V---V-L(DNY~WIWFAPDRE 97 
m-Itk KC~IV---K--------------SD----fSI----PCHYKYPFQTLVYLQWRDNYL~~~p~CE 103 
h-Atk TCIVF~PEKNPPPERQIPRRGEESSEMEQ~S~IERFP--Y--PFP--V---W-DEGPLYVFSPTEE 119 
m-Tecl __--------------____---___________--_p------_~_----___----__----__-- 16 
h-Itk SRQR~~nEET~NS-LVPKYI1PNFWM)GKWRCCSQLE~TGCAQMPTKNA--S--------- 153 
m-Itk SRQRWVLTLKEE1RNNNS-LVSKY~~F~~RWRCCSQLE~AVG~YDpS~A--S--------- 159 
h-Atk LRKRWIHQLKNVIRYN-SDLVQKYHPCFWIDGQYLCCSQT~~C-QILENRNG--SLKPGSSHRK 183 
m-Tecl SRDRWVKKLKEEIKNNNN-IMIKYRPKFWADGSYQCCRQTE~~GCEKY----WLFES--------- 70 
h-Itk 
m-Itk 
h-Atk 
m-Tecl 
-X--~L~~TBE-DN-RR--PLW-E-P-EE----T-----WIA~YDYQ-T-N--DPQELA--LR--R 
-K--KPLPPTPE-DN-RR--SFQ-E-P-EE----T-----LVIALYDYQ-~-N--DPQE~--LR--C 
TK--KPLPPTPEEDQ-ILKKPLPPE-P-AAAPVSTSELKKW-~YQYM-PMNADLQ-L----R--K 
-SIRK?ZPPAPE-IKKAR--PPP-PIPPEE--ENT--EEIW-AMYDFQAT-------E-AHDLRLER 
[____----___-----_--sA3--___--- 
194 
200 
237 
120 
h-Itk 
m-Itk 
h-Atk 
m-Tecl 
NEEYCWDSSE'I---HWWRVQDRNGflEGYVPSSYLV-ER--SPNNLETYEWYNKSISRDKAERLLLDT 
3EEYYUtlS~EI---HWWRVQDKNGHEGYAPSSYLV-EK--SPNNLETYE~fNKSISR~~BK~L~~ 
GDEYFIfEESNL---PWWtZARDKNGQEGYIPSNY-VTEAEDSI---EMYEWYSKHMTRSQAEQ~LKQE 
GQeYIIL---EKNDLH~RARaKYGW--YCR------------N---T----NRS----KAEQLtR-T 
--~_________________-__-------___ I [_---____--_____-_ 
256 
262 
298 
159 
h-Itk 
m-Itk 
h-Atk 
m-Tecl 
319 
324 
358 
222 
h-Itk 
m-Itk 
h-Atk 
m-Tecl 
INYHQHP1GGGLVVTRLRYPVCF-GRQ-K-APVTAGLRYGKWDPSELTFtrQEIGSGQFGLN 
IQYHQYNGGGLVTRLRYPVCS-WRQ-R-APVTAGLRYGKWVIQPSELTFVQEIGSGQFGLVHLGYWLN 
I~HQHNSAGLISRLKYPVSQ---QNKNAPSTAGLGYGSWEIDFKDL~L~L~GQFGWKYGKWRG 
IEYHKHNAAGLVTRLRYPVSTKG---KNAPTTAGFSYDRWEINPSELTFMRELGSGLFGVVRtCK 
1 [_---___----__-----_-- 
384 
389 
423 
287 
h-Itk X-DKVAIKTIAEG~SEED-FIEEAEVMMKLSHPKLVPLYGVCLEQAFICLVF---EFMEHGCLSDYL 447 
m-Itk K-aKVAXKTIQ~G~EED-FIEEAEVEIIMKLSHPKLVQLYG\tCL~Q~~CLVF---EFMERGCLSDYI, 452 
h-Atk QYD-VAIKMIK~SMSE-DEFIEEAKVMMLSHE~LV~LYGVCTKQ~~---FIITEYMANGCLLNYT, 486 
m-TeclQ-YKVi4IKAIREGBMCEED-FI~~A~M~~PKLVQLY~CT~KP~YIVT---~FM~R~LLNF~ 350 
h-Itk RTQR-OltFAAliT--LL~LDVCEG~YLEEA~IHRDWLARNCLVGISN-Q-VIKVSDFGFITRFVWlD 
m-Itk RSQR-GLFAAET--LLGMCLDVCEGMAYLEWLCVI~~NCLVGEN-Q-VIKVSDFGMT~DD 
h-Atk REMR-HRFQ--TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGWKVSDFGLSRYVLDD 
m-TeclR-QRQGHFSRDM--LLSMCQDVCEGMEYLERNSFI~L~NCLVNEA-G-~~SDFG~YVLDD 
__-______-KinaPe catalytic domain----_------_-----------__---____--_ 
h-Itk Q;TSSTGTE;FPVKWASp-EVf--S-FSRYSSKSD~SFrmLMWEVFSEGKIPYE-NRS-NSEWEDIS 
m-Itk QYTSSTGTKFPVWRSP-EVF--S-PSRYSSICSDVWSFG~EVFSEGK~PYE-NRS-NSBVVEDIS 
h-Atk EYTSSVGSKFPVRW-SPPBVMYSKFS--S-KSDIWAFC;rlLMWGIYSLGKMPYE--RFT~ETAEHIA 
~-T~~~QYTSSSGAKF~~CPP-EVF--N-YSRFSSKSDVWSPGVEIFT&GRMPFEKNT--NYEWT~~- 
510 
515 
549 
413 
572 
577 
611 
474 
h-Itk T-GFRLYKPRWSTHV-YQfMNHCWKERPED-RPAFSRLLRQ---LA---EIAES-G1, 
m-Itk T-GFRLYKI)RLASCHV-YQI~HC~KPED-RPPFSQLLSQ---LA---EIAEA-CL 
h-Atk Q-GLRLYRPHWSEKV-YTIMYSCW~~-DERPTFKILLSN--ILDVMDE--ES 
m-TeclTRGHRLHRPKLA-TKYLYE~LRCWQERPEG-RPSFEDLfRTIDELV---ECEETFGR 
--__-----____---____---____---__-----__------ 1 
620 
625 
659 
527 
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Fig. 1. (B) Schemattc comparison of human ttklrd wtth a .SYC famtly 
protein tyrosine kinase. M, Ya and Yn mdtcate the myrtstylatton. the 
putative autophosphorylation and the negative regulatory site, respec- 
ttvely. as described m the text. 
the cloned tyrosine kinase were at positions 339-338 
and at positions to adjacent to the SH2 domain, respec- 
tively. Number as well as the order of the SH2 and SH3 
domains, together with the kinase catalytic region in the 
clone was the same as those of non-receptor SY~ family 
tyrosine kinases (Fig. 1 B). No typical hydrophobic re- 
gion was seen, indicating that it is present in the cyto- 
plasm. A computer search confirmed that the clone is 
novel, having high similarity to the members of the .~I’( 
family, Drosophila src28C [17]. human I&. human fgr 
[ 181, human_f\sn and mouse tee type I [ 191. These results 
strongly lend support to the fact that our clone encodes 
a cytoplasmic tyrosine kinase. 
It should be noted that our clone is close to the mouse 
tee type I gene preferentially expressed in liver because 
it codes for a cytoplasmic tyrosine kinase that is related 
to but significantly distinct from the SYC’ family. Both 
clones lack a tyrosine residues which is known to be a 
negative regulatory site of the src-family tyrosine ki- 
nases at the C-terminal [20-221 and have rather shorter 
C-terminals, suggesting different mechanisms by which 
phosphate transfer activities are regulated. Other dis- 
tinct figures are found in amino acid sequences up- 
stream of the SH3 domain which are longer than those 
of the SYC family tyrosine kinases, and do not have a 
myristylation site at their amino ends which enable the 
src members to be attached to the inner surface of the 
cell membrane (Fig. 1B). This may suggest differences 
in subcellular localization as well as signaling roles. 
Very recently, having prepared this report, we learned 
that two novel kinases have been cloned; itkltsk isolated 
from mouse T cells [23,24], and utklhpk from human B 
cells [25,26], both of which have the SH3, SH2 and 
tyrosine kinase domains in order and lack the tyrosine 
residue in the C-terminals and the myristylation site at 
the amino ends. Surprisingly. striking similarity be- 
tween these molecules and our clone was observed with 
amino acid homology of 93% to mouse itkltsk, 53% to 
human atk and 50% to mouse tee type I. Thus our clone 
is believed to be a human counterpart of the mouse 
itkltsk gene. Due to these similarities in sequence and 
structural organization, these clones, human and mouse 
itkltsk, mouse tee type I and human atklbpk. seem to 
establish a new subfamily among non-receptor type ty- 
rosine kinases. 
Expression of the human itkltsk gene was examined 
by RNA blot analyses with a variety of human cell lines. 
Under high stringent hybridization conditions, the 
human itk cDNA probe identified a single RNA tran- 
script of 4.4-kb in restricted cell lines, mainly in T cell 
lines (Fig. 2). Low to moderate expression of human 
itkltsk mRNA was seen in T cell lines Jurkat and 
MOLT-4, and in an HTLV-I-infected T cell line, MT-l 
and relatively high in HTLV-I-producing T cell lines. 
TL-Su. ILT-Mat, MT-2, HUT 102, TCL-Kan and TL- 
Mor. Moderate level of expression was also seen in a 
natural killer cell line YTC3 but not detected in B cell 
lines. Raji. BALL-l, Ramos. LCL-Kan, LCL-Ter28 
and Daudi. Expression of human itkltsk mRNA was 
not detected in other hematopoietic cell lines, a promon- 
ocytic cell line THP-1, an erythroleukemic cell line 
K562, a promyelocytic cell line HL-60 and an eo- 
sinocytic cell line Eol 3. and also totally undetectable in 
a non-hematopoietic cell, an epithelioid cell line HeLa, 
fibroblastoid cell lines WI26 and WI38, a neuroblas- 
toma cell line SK-N-SH, glioma cell lines Hs683 and 
Onda 11, a fibrosarcoma cell line HT- 1080, an epider- 
moid carcinoma KB and a hepatocellular carcinoma 
Hep G2 (data not shown). These results demonstrate 
that the human itkltsk gene expression is restricted in T 
and natural killer cell lines. 
We next examined whether expression of the human 
itkltsk gene is enhanced upon stimulation leading to T 
cell activation. Low level expression of itkltsk mRNA 
in unstimulated PBL was converted to the level as high 
as in HTLV-I-expressing T-cell lines after PHA plus 
IL-2 stimulation (Fig. 3A). IL-2 alone was enough for 
the significant induction in MT/?-l. as shown with the 
mouse itkltsk [23], and this level was observed to be 
maximum 6 h after stimulation (Fig. 3B). This may 
imply a possible role of itkltsk in T cell activation and 
GAPDH- ~ti~~~~_U~~ 
Fig. 2. RNA blot analysis of human rtkltsk mRNA in varrous cells. 
The cDNA from pN? was used to detect a 4.4-kb message. Total RNA 
(20,~g) was electrophoresed m a denatured 2% agarose-formaldehyde 
gel and transferred to membranes. After hybridtzatton wtth the human 
ttk/t.sk probe, they were rehybrtdaed wrth the GAPDH probe as con- 
trol. A prolonged exposure revealed a famt 4.4-kb stgnal in MT-I 
4 
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3APDH 
B 
Time (hr) 
0 1 6 122448 
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4.4-kb & 
GAPDH 
Fig. 3. Induction of human itkltsk mRNA by IL-2 (A) Total RNA 
from PBL was extracted before and after the stimulation with PHA. 
Two days after PHA stimulation. IL-2 was added at a concentratton 
of 1 nM and cultured for another 2 days. (B) MT/?-l cells were sttm- 
mated by 2 nM IL-2 Cells were harvested after 0, 1. 6. 12, 24 and 48 
h. Total RNA (30 pg) was electrophoresed for each lane 
proliferation. Indeed, expression of the mouse itkltsk 
gene was shown to be developmentally regulated [24]. 
In this context, the recently cloned human B-cell specific 
clone, atklbpk, was interestingly demonstrated to be in- 
volved in X-linked agammaglobulinemia, suggesting its 
crucial role in B-cell ontogeny. Similarly, since our 
human itkltsk clone is a member of the same subfamily 
of tyrosine kinases, we cannot ignore the possibility that 
the itkltsk product plays a pivotal role in T cell develop- 
ment and that its impairment results in T cell or T and 
B cell combined immunodeficiency as observed in 
human severe combined immunodeficiency (KID) [27]. 
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